Department of Biology, University of Pisa, via San Zeno, 31, 56127 Pisa, Italy.
Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health", University of Pisa, via del Borghetto 80, 56124 Pisa, Italy.
Nutrients. 2020 Apr 23;12(4):1189. doi: 10.3390/nu12041189.
There is indication that nutritional supplements protect retinal cells from degeneration. In a previous study, we demonstrated that dietary supplementation with an association of forskolin, homotaurine, spearmint extract and B vitamins efficiently counteracts retinal dysfunction associated with retinal ganglion cell (RGC) death caused by optic nerve crush. We extended our investigation on the efficacy of dietary supplementation with the use of a mouse model in which RGC degeneration depends as closely as possible on intraocular pressure (IOP) elevation. In this model, injecting the anterior chamber of the eye with methylcellulose (MCE) causes IOP elevation leading to RGC dysfunction. The MCE model was characterized in terms of IOP elevation, retinal dysfunction as determined by electrophysiological recordings, RGC loss as determined by brain-specific homeobox/POU domain protein 3A immunoreactivity and dysregulated levels of inflammatory and apoptotic markers. Except for IOP elevation, dysfunctional retinal parameters were all recovered by dietary supplementation indicating the involvement of non-IOP-related neuroprotective mechanisms of action. Our hypothesis is that the diet supplement may be used to counteract the inflammatory processes triggered by glial cell activation, thus leading to spared RGC loss and the preservation of visual dysfunction. In this respect, the present compound may be viewed as a potential remedy to be added to the currently approved drug therapies for improving RGC protection.
有迹象表明,营养补充剂可保护视网膜细胞免受变性。在之前的一项研究中,我们证明了膳食补充物(包含毛喉素、高同型半胱氨酸、薄荷提取物和 B 族维生素)可有效对抗因视神经挤压导致的视网膜神经节细胞(RGC)死亡引起的视网膜功能障碍。我们使用一种尽可能接近眼压(IOP)升高的鼠模型,进一步研究了膳食补充的功效。在这种模型中,向眼前房注射甲基纤维素(MCE)会导致 IOP 升高,从而导致 RGC 功能障碍。MCE 模型的特点是眼压升高、视网膜功能障碍(通过电生理记录确定)、RGC 损失(通过脑特异性同源盒/POU 结构域蛋白 3A 免疫反应性确定)和炎症及凋亡标志物水平失调。除了 IOP 升高之外,视网膜功能障碍参数均通过膳食补充得到恢复,这表明存在与 IOP 无关的神经保护作用机制。我们的假设是,饮食补充剂可能用于对抗由神经胶质细胞激活引发的炎症过程,从而导致 RGC 损失减少和视觉功能障碍得到保留。在这方面,本化合物可被视为一种潜在的治疗方法,可与目前批准的药物疗法一起用于改善 RGC 保护。